1. Home
  2. HLI vs CTLT Comparison

HLI vs CTLT Comparison

Compare HLI & CTLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLI
  • CTLT
  • Stock Information
  • Founded
  • HLI 1972
  • CTLT 2007
  • Country
  • HLI United States
  • CTLT United States
  • Employees
  • HLI N/A
  • CTLT N/A
  • Industry
  • HLI Investment Managers
  • CTLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • HLI Finance
  • CTLT Health Care
  • Exchange
  • HLI Nasdaq
  • CTLT Nasdaq
  • Market Cap
  • HLI 11.8B
  • CTLT 11.0B
  • IPO Year
  • HLI 2015
  • CTLT 2014
  • Fundamental
  • Price
  • HLI $188.54
  • CTLT $59.66
  • Analyst Decision
  • HLI Hold
  • CTLT Hold
  • Analyst Count
  • HLI 6
  • CTLT 6
  • Target Price
  • HLI $157.00
  • CTLT $63.40
  • AVG Volume (30 Days)
  • HLI 323.4K
  • CTLT 1.7M
  • Earning Date
  • HLI 10-30-2024
  • CTLT 11-05-2024
  • Dividend Yield
  • HLI 1.20%
  • CTLT N/A
  • EPS Growth
  • HLI 30.39
  • CTLT N/A
  • EPS
  • HLI 4.89
  • CTLT N/A
  • Revenue
  • HLI $2,119,860,999.00
  • CTLT $4,422,000,000.00
  • Revenue This Year
  • HLI $21.25
  • CTLT $8.58
  • Revenue Next Year
  • HLI $14.17
  • CTLT $7.95
  • P/E Ratio
  • HLI $38.78
  • CTLT N/A
  • Revenue Growth
  • HLI 18.82
  • CTLT 4.71
  • 52 Week Low
  • HLI $104.86
  • CTLT $36.74
  • 52 Week High
  • HLI $191.39
  • CTLT $61.20
  • Technical
  • Relative Strength Index (RSI)
  • HLI 67.13
  • CTLT 54.29
  • Support Level
  • HLI $181.48
  • CTLT $58.39
  • Resistance Level
  • HLI $185.81
  • CTLT $60.21
  • Average True Range (ATR)
  • HLI 3.90
  • CTLT 0.58
  • MACD
  • HLI 0.11
  • CTLT 0.05
  • Stochastic Oscillator
  • HLI 87.01
  • CTLT 71.28

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About CTLT Catalent Inc.

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Share on Social Networks: